[Preliminary study of the therapeutic effect of superoxide dismutase in 7 cases of Behçet's disease].
Neutrophils of patients with Behçet's syndrome generate increased amounts of oxygen free radicals. This phenomenon is inhibited by superoxide dismutase (SOD) and catalase and is implicated in vasculitis. We treated seven patients with active Behçet's syndrome by CuZn SOD intramuscularis with dramatic improvement of clinical symptoms.
Emerit
J
J
Jeny
C
C
Emerit
I
I
Le Hoang
P
P
Caen
O L
OL
Pelletier
S
S
Mollet
M
M
Congy
F
F
D000328:Adult; D001528:Behcet Syndrome / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D013482:Superoxide Dismutase / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D013482:Superoxide Dismutase
Etude préliminaire de l'effet thérapeutique de la superoxyde dismutase dans sept cas de maladie de Behçet.